GE HealthCare Technologies (GEHC) Could Be 19% Undervalued As Imaging Push Gains Ground

GE HealthCare Technologies (GEHC) has put molecular imaging in focus after securing CE Mark approval for its MINItrace Magni cyclotron and widening PETtrace Solid Target capabilities to include Copper-64 production. GE HealthCare Technologies has seen mixed momentum around these updates, with the 7-day share price return up 5.83% and the 30-day move up 9.58%, yet the year-to-date share price still down 16.00% and the 1-year total shareholder return lower by 5.87%, even as product launches...